Operator of a biotechnology firm intended to convert agricultural waste streams into specialty chemicals. The company harnesses the power of biology to convert the low value, abundant fruit and vegetable byproducts like citrus peels and sugar beet pulp into high performing useful products, such as household cleaning ingredients, bio-based plastics, vitamins, enabling clients to receive…

Developer of non-hormonal contraceptives designed to eliminate the risk of negative side-effects associated with traditional hormonal contraceptives. The company’s products work by blocking a protein on sperm that is required for fertilization, enabling customers to use safer birth control options with no side-effects for men and women.

Biotechnology research and development.

Developer of genetic skin disease drug designed to improve the healing and integrity of the skin. The company’s drugs are focused on wound care, pain management and itch management, enabling patients treatment of mutation causing dystrophic epidermolysis bullosa.

Producer of sustainable pet foods designed to serve dogs and cats. The company’s pet foods are prepared with cultured protein that is good for pets and the environment and contains no animal by-products or rendered animals, enabling pets to get all the nutritional needs and stay healthy. Wild Earth aims to create the perfect food…

WellSIM Biomedical Technologies, Inc. is a liquid biopsy biotechnology company developing and commercializing complete diagnostic solutions for non-invasive cancer testing through enrichment, isolation, and analytical interrogation of exosomes and extracellular vesicles from specimens such as plasma, urine, and saliva.

Developer of a biotechnology drug designed to act precisely within a targeted diseased tissue. The company’s technology platform modifies drugs to improve their stability and target specificity, thereby reducing the frequency of administration required for effective treatment, enabling physicians to improve the treatment of many diseases.

Provider of big data services intended to facilitate genomics discovery. The company’s services specializes in harnessing the power of full genome sequencing and scalable computing using machine learning for large-scale genomic analyses, enabling biopharmaceutical and clinical research industries to inform and shape clinical trials.

Development and sales of cell analysis instruments for research use.